Kernicterus Treatment Global Market Report 2024: Key Players, Demand Patterns And Forecasts 2033 | Pfizer Inc., F. Hoffmann-La Roche Ltd , Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2143

The Business Research Company offers in-depth market insights through Kernicterus Treatment Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The kernicterus treatment market size has grown steadily in recent years. It will grow from $2.88 billion in 2023 to $2.98 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to improvements in neonatal care practices, increased awareness among healthcare professionals, government initiatives for maternal and child health, research funding and clinical trials, collaborations in medical research..

The kernicterus treatment market size is expected to see steady growth in the next few years. It will grow to $3.29 billion in 2028 at a compound annual growth rate (CAGR) of 2.6%. The growth in the forecast period can be attributed to continuous medical education programs, global health policies and initiatives, patient advocacy and support groups, international collaboration in pediatric research, government funding for neonatal health.. Major trends in the forecast period include advancements in neonatal jaundice monitoring technologies, introduction of phototherapy devices with enhanced features, development of bilirubin-reducing medications, focus on home-based phototherapy solutions, implementation of bilirubin nomograms and guidelines, integration of telehealth for remote monitoring..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13470&type=smp

Market Segmentation:
The main types of kernicterus treatments are phototherapy, intravenous immunoglobulins (ivig), blood transfusion, medication and others. Phototherapy refers to a medical treatment that uses light, typically in the form of specialized lights or lamps. It is used to treat various symptoms such as jaundice, unusual eye movements, vomiting, fever, poor feeding, apnea, irritability, seizures, sleepiness, and others, and involve dosage intake through injections, solutions, and others. It includes a variety of end users such as clinics, hospitals, and others.

Major Driver - Significant Role Of Neonatal Jaundice Prevalence In Driving the Kernicterus Treatment Market Growth
The prevalence of neonatal jaundice is driving the growth of the kernicterus treatment market going forward. Neonatal jaundice, also known simply as jaundice in newborns, is a common and typically harmless condition characterized by the yellowing of a baby's skin and the whites of their eyes. Kernicterus treatment is commonly used for neonatal jaundice; it manages the symptoms and provides supportive care. This procedure removes blood from the baby and replaces it with blood with a lower bilirubin level, improving the affected child's quality of life. For instance, in August 2023, according to reports published by the National Library of Medicine, a US-based biomedical library, globally, about 1.1 million babies each year develop severe neonatal hyperbilirubinemia (neonatal jaundice). Furthermore, in February 2021, according to ClinMed International Library, a US-based publishing company, it was estimated that at least 114,000 infants die yearly from neonatal hyperbilirubinemia (neonatal jaundice). Therefore, the prevalence of neonatal jaundice is expected to propel the growth of the kernicterus treatment market.

Competitive Landscape:
Major companies operating in the kernicterus treatment market report are Pfizer Inc., F. Hoffmann-La Roche Ltd , Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, AstraZeneca plc., Abbott Laboratories, Sanofi SA, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Johnson and Johnson Private Limited, Baxter International Inc., Grifols S.A, Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Alembic Pharmaceuticals Limited, Lupin Pharmaceuticals Inc., CSL Limited, Glenmark Pharmaceuticals Ltd., Cipla Inc., Torrent Pharmaceuticals Ltd., Octapharma Brasil Ltda, Kedrion S.p.A, Biotest AG, Wockhardt Ltd., Mylan N.V., Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., China Biologic Products Holdings Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/kernicterus-treatment-global-market-report

Top Trend - Innovative Wearable Devices Revolutionizing Kernicterus Monitoring And Treatment In Infants
Major institutes operating in the kernicterus treatment market are developing innovative technological products, such as wearable devices to monitor jaundice accurately, that help gain a competitive advantage. A wearable device is a small, flexible patch placed on the body according to the treatment requirement. For instance, in March 2021, Yokohama National University, a Japan-based university, designed the first-ever wearable device to accurately monitor jaundice, a yellowing of the skin due to increased bilirubin levels in the blood that can result in severe medical conditions in infants. This wearable sensor for infants can constantly measure bilirubin to achieve the intricate balance of administering the accurate amount of blue light required to neutralize the correct bilirubin levels. Moreover, it is a small, flexible patch that is placed on the infant's chest, and it transmits data to a smartphone or computer, where doctors or parents can monitor it. Also, it is more accurate and convenient than traditional methods of monitoring jaundice, such as blood tests.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Kernicterus Treatment Market Characteristics
3. Kernicterus Treatment Market Trends And Strategies
4. Kernicterus Treatment Market - Macro Economic Scenario
5. Kernicterus Treatment Market Size And Growth
…..
27. Kernicterus Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.